Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Yan-Kit Kwong, M.D.

Co-Author

This page shows the publications co-authored by Raymond Kwong and Ravi Shah.
Connection Strength

5.703
  1. Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients. JACC Cardiovasc Imaging. 2014 May; 7(5):462-72.
    View in: PubMed
    Score: 0.609
  2. Role of cardiac MRI in diabetes. Curr Cardiol Rep. 2014 Feb; 16(2):449.
    View in: PubMed
    Score: 0.602
  3. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013 Aug 06; 128(6):605-14.
    View in: PubMed
    Score: 0.577
  4. Tissue characterization with cardiac MR imaging: a new hope for improving the cardiac outlook of patients with impaired fasting glucose? Radiology. 2012 Mar; 262(3):742-5.
    View in: PubMed
    Score: 0.527
  5. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy. PLoS One. 2016; 11(11):e0164914.
    View in: PubMed
    Score: 0.182
  6. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation. 2016 Aug 02; 134(5):378-91.
    View in: PubMed
    Score: 0.179
  7. Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia. Circ Cardiovasc Imaging. 2016 Apr; 9(4):e004136.
    View in: PubMed
    Score: 0.175
  8. Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging. 2015 Apr; 8(4):414-423.
    View in: PubMed
    Score: 0.163
  9. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014 Dec; 7(12):1221-35.
    View in: PubMed
    Score: 0.159
  10. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging. 2014 Nov; 7(6):887-894.
    View in: PubMed
    Score: 0.158
  11. Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease. Am J Cardiol. 2014 Oct 15; 114(8):1198-203.
    View in: PubMed
    Score: 0.156
  12. Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Prev Cardiol. 2015 Nov; 22(11):1408-18.
    View in: PubMed
    Score: 0.155
  13. Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation. Circ Cardiovasc Imaging. 2014 Jul; 7(4):586-92.
    View in: PubMed
    Score: 0.154
  14. Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function. Am Heart J. 2014 Apr; 167(4):620-6.
    View in: PubMed
    Score: 0.150
  15. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014 Jan; 7(1):1-11.
    View in: PubMed
    Score: 0.149
  16. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013 Nov 25; 2(6):e000421.
    View in: PubMed
    Score: 0.149
  17. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol. 2013 Dec 10; 62(23):2205-14.
    View in: PubMed
    Score: 0.146
  18. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013 Aug 20; 2(4):e000279.
    View in: PubMed
    Score: 0.146
  19. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013 Sep; 6(9):944-54.
    View in: PubMed
    Score: 0.145
  20. Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013 Jun 14; 15:52.
    View in: PubMed
    Score: 0.144
  21. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013 Apr 23; 61(16):1698-706.
    View in: PubMed
    Score: 0.143
  22. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013 May 01; 6(3):415-22.
    View in: PubMed
    Score: 0.142
  23. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol. 2012 Dec 01; 110(11):1679-86.
    View in: PubMed
    Score: 0.136
  24. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016 Dec; 9(12).
    View in: PubMed
    Score: 0.046
  25. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016 Sep 26; 5(9).
    View in: PubMed
    Score: 0.045
  26. T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol. 2014 Dec; 30(12):1668-75.
    View in: PubMed
    Score: 0.039
  27. Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes. 2015 Jan; 64(1):236-42.
    View in: PubMed
    Score: 0.039
  28. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc. 2014 Jun 25; 3(3):e000790.
    View in: PubMed
    Score: 0.039
  29. Right heart failure: an ischemic model and restraint therapy for treatment. Ann Thorac Surg. 2014 Apr; 97(4):1356-62; discussion 1362-3.
    View in: PubMed
    Score: 0.038
  30. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson. 2013 Oct 01; 15:89.
    View in: PubMed
    Score: 0.037
  31. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013 Sep 10; 128(11):1225-33.
    View in: PubMed
    Score: 0.036
  32. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging. 2013 Jun; 6(6):672-83.
    View in: PubMed
    Score: 0.036
  33. Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol. 2013 Jul 01; 112(1):73-8.
    View in: PubMed
    Score: 0.036
  34. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013 Mar 01; 111(5):717-22.
    View in: PubMed
    Score: 0.035
  35. Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail. 2013 Jan; 6(1):99-106.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.